Seeking men and women who have non-small cell lung cancer removed and the cancer tumor has a change in the gene called the PD-L1 gene for a study of an investigational immunotherapy drug added to the usual chemotherapy.
Participants in this study will be randomly assigned to get the usual chemotherapy for 4 months, the usual chemotherapy for 4 months followed by immunotherapy with the investigational drug for one year, or both the usual chemotherapy and immunotherapy with the investigational drug for 4 months followed by immunotherapy with the investigational drug for 10 months.
What we're hoping for
We are studying whether adding an investigational immunotherapy drug to the usual chemotherapy for non-small lung cancer which has PD-L1 gene changes is better or worse that the usual chemotherapy alone.
ClinicalTrials.gov Identifier: NCT04267848